Larimar Therapeutics (LRMR) Research & Development: 2012-2019
Historic Research & Development for Larimar Therapeutics (LRMR) over the last 8 years, with Dec 2019 value amounting to $23.9 million.
- Larimar Therapeutics' Research & Development fell 96.31% to $423,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $23.9 million, marking a year-over-year decrease of 50.16%. This contributed to the annual value of $23.9 million for FY2019, which is 50.16% down from last year.
- Larimar Therapeutics' Research & Development amounted to $23.9 million in FY2019, which was down 50.16% from $47.9 million recorded in FY2018.
- Larimar Therapeutics' 5-year Research & Development high stood at $54.6 million for FY2015, and its period low was $23.9 million during FY2019.
- Its 3-year average for Research & Development is $37.6 million, with a median of $40.8 million in 2017.
- As far as peak fluctuations go, Larimar Therapeutics' Research & Development skyrocketed by 99.40% in 2015, and later plummeted by 50.16% in 2019.
- Yearly analysis of 5 years shows Larimar Therapeutics' Research & Development stood at $54.6 million in 2015, then dropped by 26.88% to $39.9 million in 2016, then increased by 2.26% to $40.8 million in 2017, then climbed by 17.36% to $47.9 million in 2018, then plummeted by 50.16% to $23.9 million in 2019.